-
IntroducedMar 01, 2024
-
Passed SenateMay 01, 2024
-
Passed HouseMay 22, 2024
-
Signed into LawMay 28, 2024
PHARMACEUTICALS: Provides relative to opioid alternatives. (8/1/24) (EN NO IMPACT See Note)
Last Action See all actions
Senate • May 28, 2024: Effective date 8/1/2024.
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 224
Tweets
Whip Lists
Sponsors
Votes
YES: 96
- Adams
- Domangue
- Marcelle
- Amedee
- Echols
- McCormick
- Bacala
- Edmonston
- McFarland
- Bagley
- Egan
- McMahen
- Bamburg
- Emerson
- McMakin
- Bayham
- Farnum
- Melerine
- Beaullieu
- Firment
- Mena
- Berault
- Freeman
- Miller
- Billings
- Freiberg
- Muscarello
- Bourriaque
- Gadberry
- Myers
- Boyd
- Galle
- Newell
- Boyer
- Glorioso
- Orgeron
- Brass
- Green
- Owen
- Braud
- Hebert
- Riser
- Brown
- Henry
- Romero
- Bryant
- Hilferty
- Schamerhorn
- Butler
- Horton
- Schlegel
- Carlson
- Hughes
- St. Blanc
- Carpenter
- Illg
- Stagni
- Carrier
- Jackson
- Tarver
- Carter, R.
- Johnson, M.
- Taylor
- Carter, W.
- Johnson, T.
- Thomas
- Carver
- Jordan
- Thompson
- Chassion
- Kerner
- Turner
- Chenevert
- Knox
- Ventrella
- Coates
- LaCombe
- Villio
- Cox
- LaFleur
- Wilder
- Crews
- Landry, J.
- Wiley
- Davis
- Landry, M.
- Willard
- Deshotel
- Larvadain
- Wright
- Dewitt
- Lyons
- Wyble
- Dickerson
- Mack
- Zeringue
NO: 0
Actions
- May 28, 2024 | Senate
- Sent to the Governor by the Secretary of the Senate on 5/23/2024.
- Signed by the Governor. Becomes Act No. 320.
- Effective date 8/1/2024.
- May 23, 2024 | House
- Signed by the Speaker of the House.
- May 23, 2024 | Senate
- Enrolled. Signed by the President of the Senate.
- May 22, 2024 | Senate
- Received from the House without amendments.
- May 22, 2024 | House
- Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, ordered to the Senate.
- May 21, 2024 | House
- Read by title, passed to 3rd reading.
- Scheduled for floor debate on 05/22/2024.
- May 20, 2024 | House
- Reported without Legislative Bureau amendments.
- May 15, 2024 | House
- Reported favorably (11-0). Referred to the Legislative Bureau.
- May 07, 2024 | House
- Read by title, under the rules, referred to the Committee on Health and Welfare.
- May 06, 2024 | House
- Received in the House from the Senate, read by title, lies over under the rules.
- May 01, 2024 | Senate
- Read by title, passed by a vote of 39 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
- Apr 30, 2024 | Senate
- Rules suspended. Recalled from Committee.
- Read by title and passed to third reading and final passage.
- Apr 29, 2024 | Senate
- Read by title. Committee amendments read and adopted; ordered engrossed and recommitted to the Committee on Finance.
- Apr 24, 2024 | Senate
- Reported with amendments.
- Mar 11, 2024 | Senate
- Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Health and Welfare.
- Mar 01, 2024 | Senate
- Prefiled and under the rules provisionally referred to the Committee on Health and Welfare.